[Improved survival in advanced or metastatic prostate cancer with initial androgen deprivation and concomitant abiraterone]

Strahlenther Onkol. 2018 Mar;194(3):266-268. doi: 10.1007/s00066-017-1252-4.
[Article in German]
No abstract available

Publication types

  • Comment

MeSH terms

  • Androgen Antagonists
  • Androstenes*
  • Humans
  • Male
  • Prostatic Neoplasms*

Substances

  • Androgen Antagonists
  • Androstenes
  • abiraterone